Integral Diagnostics Ltd (ASX:IDX)
A$ 2.92 0.05 (1.74%) Market Cap: 1.07 Bil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 2.22 GF Score: 85/100

Half Year 2020 Integral Diagnostics Ltd Earnings Call Transcript

Feb 19, 2020 / 11:00PM GMT
Release Date Price: A$3.9 (-2.71%)
Operator

Thank you for standing by, and welcome to the Integral Diagnostics Limited H1 FY 2020 Results Presentation. (Operator Instructions)

I would now like to hand the Ian Kadish, Managing Director and CEO. Please go ahead.

Ian Kadish
Integral Diagnostics Limited - CEO, MD & Director

Thank you, operator, and thank you all for joining the call. My name is Ian Kadish, I'm the Managing Director and Chief Executive of Integral Diagnostics. I'm joined this morning by Anne Lockwood, our Chief Financial and Commercial Officer. We are pleased to be talking to you today to discuss our results for the first half of financial year '20.

I'll start with reviewing the financial highlights. We delivered above-market organic growth as well as growth from acquisitions in the first half. We grew our operating revenue by 15.3%, and we grew both our operating EBITDA and our operating net profit after tax by about 10%. We also grew our statutory net profit after tax by 1.9%. We completed the acquisition of the Imaging Queensland Group effective from the one -- from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot